James V Tricoli

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer
    James V Tricoli
    Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Blvd, Executive Plaza North, Rockville, MD 20852, USA
    J Natl Cancer Inst 103:628-35. 2011
  2. ncbi request reprint Detection of prostate cancer and predicting progression: current and future diagnostic markers
    James V Tricoli
    Diagnostics Research Branch, Cancer Diagnosis Program, National Cancer Institute, Rockville, Maryland, USA
    Clin Cancer Res 10:3943-53. 2004
  3. pmc Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
    Lisa M McShane
    Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Room 5W130, MSC 9735, 9609 Medical Center Drive, Bethesda, MD 20892 9735, USA
    BMC Med 11:220. 2013
  4. ncbi request reprint MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis
    James V Tricoli
    Diagnostic Biomarkers and Technology Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland 20852, USA
    Cancer Res 67:4553-5. 2007

Collaborators

  • Barbara A Conley
  • Lisa M McShane
  • David A Eberhard
  • Mei Yin C Polley
  • Margaret M Cavenagh
  • Jill P Mesirov
  • Richard M Simon
  • William L Bigbee
  • P Mickey Williams
  • Deborah J Shuman
  • Kelly Y Kim
  • Tracy G Lively
  • James H Doroshow
  • Jeremy M G Taylor

Detail Information

Publications4

  1. pmc Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer
    James V Tricoli
    Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Blvd, Executive Plaza North, Rockville, MD 20852, USA
    J Natl Cancer Inst 103:628-35. 2011
    ....
  2. ncbi request reprint Detection of prostate cancer and predicting progression: current and future diagnostic markers
    James V Tricoli
    Diagnostics Research Branch, Cancer Diagnosis Program, National Cancer Institute, Rockville, Maryland, USA
    Clin Cancer Res 10:3943-53. 2004
    ..Finally, we discuss how to conduct evaluations of candidate prostate cancer markers and some of the issues involved in the validation process...
  3. pmc Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
    Lisa M McShane
    Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Room 5W130, MSC 9735, 9609 Medical Center Drive, Bethesda, MD 20892 9735, USA
    BMC Med 11:220. 2013
    ..The US National Cancer Institute plans to refer to these guidelines for review of proposals for studies involving omics tests, and it is hoped that other sponsors will adopt the checklist as well...
  4. ncbi request reprint MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis
    James V Tricoli
    Diagnostic Biomarkers and Technology Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland 20852, USA
    Cancer Res 67:4553-5. 2007